|
|
 |
List of Abstract Tracks and Categories
Track A: Basic Science
Scope and Objectives:
This track will highlight all aspects of HIV structure, replication, and the host immune responses and will lead to a greater understanding of HIV pathogenesis. The scope will also include drug discovery, research on vaccines and advancements in animal models.
A1 HIV envelope, receptors, and entry
A2 Molecular regulation: reverse transcription through assembly
A3 Viral dynamics and latency
A4 Viral diversity
A5 Mechanisms of HIV-induced immune dysfunction
A6 HIV and other organ systems
A7 Cofactors/co-infections in HIV disease
A8 Humoral immunity
A9 Cellular immunity
A10 Innate immunity
A11 Mucosal immunity
A12 Cytokines and chemokines
A13 Immune reconstitution
A14 Host genetics and HIV
A15 SIV and other animal retroviruses
A16 Development of new antiretroviral agents
A17 Mechanisms of antiviral resistance
A18 Immune and gene based therapies
A19 Vaccine development, preclinical studies
A20 Vaccine development, clinical trials: immunogenicity and mechanisms of breakthrough infection
Track B: Clinical Research, Treatment and Care
Scope and Objectives:
This track will highlight the latest research findings of the characteristics and clinical course of HIV infection, diagnosis and treatment of opportunistic infections and other HIV-related disorders, antiretroviral therapy and immunotherapy. Aspects of medicine and related health issues to be addressed include pediatrics, obstetrics and gynecology and dentistry. Best practices in care and treatment issues related to resource-limited settings will be emphasized.
B1 Diagnostic and monitoring tools
B2 Tuberculosis and other opportunistic infections
B3 Non-OI manifestations
B4 Pediatric HIV and treatment
B5 Clinical trials of new drugs/new strategies
B6 Initiation of therapy
B7 Salvage therapy
B8 Treatment interruption/simplification and other novel approaches
B9 IL-2 and other immune-based therapies
B10 Pharmacology/drug interactions/therapeutic drug monitoring
B11 Drug resistance
B12 Adherence
B13 Complications of ARV therapy
B14 Hepatitis and other co-infections
B15 Mother-to-child transmission and MTCT-Plus
B16 Access to care: introduction and scaling up ART to a nationwide program
B17 Models of treatment and care including that in specific populations
B18 Models of treatment and care in resource-limited settings including alternative care
B19 Role of various healthcare providers and PLWAs in HIV care
B20 Prevention of transmission ( e.g. microbicides, IDU-related harm reduction strategies, post-exposure prophylaxis)
Track C: Epidemiology and Prevention
Scope and Objectives:
This track will highlight progress in the collection, analysis and use of data that describe the distribution of HIV and the behaviours that spread it. Surveillance methods, observational studies and experimental studies will be presented. The focus will be on the design and evaluation of HIV prevention interventions as well as on the natural history of infection and demographic impact of HIV. This track will examine methodological advances in epidemiology and surveillance as well as the effective use of epidemiological data in influencing national and local responses.
HIV Epidemiology
C1 Natural history and disease progression
C2 Molecular epidemiology (subtypes)
C3 The epidemiology of HIV in generalized epidemics.
C4 Opportunistic infections (both AIDS defining and non-defining conditions and symptoms)
C5 The epidemiological impact of antiretroviral therapy and therapy for opportunistic infections on the HIV pandemic
C6 The epidemiology of HIV in health care related settings
C7 The epidemiology of MTCT
HIV Epidemiology & Prevention in Contexts of Vulnerable Population
C8 Epidemiology and prevention of HIV among injecting drug users (IDUs)
C9 Epidemiology and prevention of HIV among men who have sex with men (MSM), gay, bisexual, transgender
C10 Epidemiology and prevention of HIV among youth, adolescents and mobilized population
C11 Epidemiology and prevention of HIV in sex workers
C12 Epidemiology and prevention of STIs, and their impact on HIV epidemiology
HIV Surveillance and Program Monitoring
C13 HIV surveillance – methods, systems and data utilization
C14 Estimating and projecting the size of populations at risk and infected with HIV & statistical modelling
C15 Cost effectiveness and impact assessment, monitoring and evaluation of prevention programs
Prevention Technologies
C16 Prevention technologies (microbicides, condoms, etc)
C17 HIV Vaccine
HIV Prevention in the Context of Public Health
C18 HIV prevention interventions in institutional settings (workplaces, prisons, military, etc)
C19 Social, structural and policy interventions (including legal issues)
C20 Ethical issues in HIV-related studies & intervention programs
Track D: Social and Economic Issues
Scope and Objectives:
This track will highlight three major areas of scientific investigation concerning the social and economic dimensions of the HIV/AIDS epidemic and its impact. The first area will include studies that increase our understanding of HIV/AIDS infection, its risks along with the means to prevent it on a population-wide scale. Also included in this area are strategies to maintain the quality of life and well-being of people living with HIV/AIDS, and ways to minimise the impact of HIV/AIDS infection on individuals (children and adults), families, communities and society at large. The second and third areas in this track will highlight methodological issues and the transformation of research findings into policies, plans and programs through advocacy and other suitable measures.
D1 HIV/AIDS and the workplace
D2 Quality of life and well-being of people living with AIDS
D3 Mobile populations and HIV/AIDS
D4 Emergencies, armed conflicts and HIV/AIDS
D5 Power relations, sexuality, drugs, alcohol use and HIV/AIDS
D6 Evaluating the impact of HIV/AIDS interventions on sexual behavior
D7 Health and social systems: access and availability to HIV/AIDS prevention, care and services
D8 Ethical issues in social and economic research on HIV/AIDS
D9 Cultural and religious factors influencing HIV vulnerability and prevention
D10 The elderly and HIV/AIDS
D11 Involvement of people living with HIV/AIDS
D12 Trafficking, violence and HIV/AIDS
D13 Food security, poverty reduction and HIV/AIDS
D14 Politics, ethnicity and HIV/AIDS vulnerability
D15 Social and economic aspects for AIDS orphans and vulnerable children
D16 Social and behavioral dimensions of anti-retroviral treatment programs
D17 Utilization of socio-cultural research on HIV/AIDS for programming
D18 Methodological issues in the measurement of sexual behaviors
D19 TB and HIV: Some social and economic issues
D20 Strengthening families and communities for HIV prevention and care
Track E: Policy and Program Implementation
Scope and Objectives:
This track will highlight progress, lessons learned and evolving challenges in policy development and practice and the implementation of HIV/AIDS programs. The objectives of this track are to: share information on policy evolution and leadership of HIV/AIDS program implementation at global, regional, national and community levels; describe the impact of existing and evolving policies (HIV/AIDS and others) on HIV/AIDS program implementation; share lessons learned and provide examples of effective HIV/AIDS programs, including innovative efforts to overcome barriers to scaling-up and sustaining programs in a variety of settings (health care facilities, urban and rural communities, etc); and identify gaps in policy development based on the existing information about the HIV/AIDS situation and the availability of resources to implement and expand HIV/AIDS programs. Sessions will focus on policy and program implementation issues as described above including the broad categories of HIV/AIDS prevention, medical palliative and psychosocial care for HIV/AIDS patients, global and national support and HIV/AIDS impact mitigation/economic alleviation.
HIV/AIDS Policy Development, Evolution and Implementation
E1 Evidence based policy development; how does policy inform programs and programs inform policy?
E2 Pluralistic policy processes impacting HIV/AIDS policy (e.g., drugs, trafficking, poverty reduction, food security, peacekeeping, labor, refugees).
E3 Involvement of civil society and people living with and affected by HIV/AIDS in policy advocacy, development and implementation
E4 HIV counseling, testing, reporting and notification policies
E5 Employment and workplace policies; private sector
HIV/AIDS policies
E6 Influencing legislative processes and policy development
E7 Impact of the increased funding for HIV/AIDS (GFATM, World Bank MAP, Bilateral donors, etc) on health policies and implementation at community, provincial or regional, national and global levels
E8 Application of HIV/AIDS Research (e.g., basic sciences, clinical, and applied or operational) to policy development and implementation
Impact of HIV/AIDS Policy on Program Development and Implementation
E9 Policies and programs regarding HIV prevention, treatment and care, and those addressing social and economic issues
E10 Evaluation of HIV/AIDS policies and their impact on programs; links between policy and programs
E11 Policies affecting access to programs and services (e.g., mandatory testing – “opt out” policy as part of prevention of mother to child transmission program)
Implementation of HIV/AIDS Prevention and Care Programs
E12 Coverage and costing: going to scale
E13 Linking responses to HIV/AIDS at community, provincial, regional and national levels
E14 Monitoring and Evaluation of the prevention and care projects and national programs for effectiveness
E15 Lessons learned; successes and failures in implementation of prevention and care programs
E16 Resource mobilization and human capacity development; strengthening of PLWAs, community service organisations, and other stakeholders involved in program implementation
E17 Involvement of stakeholders (e.g., PLWA, women, youth, etc) in program design and implementation
E18 Involvement of government, private sectors and civil society (e.g., faith and other community based organisations) in program implementation
E19 Impact mitigation, economic alleviation, stigma reduction and orphan support
E20 Translating results from HIV/AIDS research into programs
|
|
|
|